Get Silicon Valley Top 1000 Contacts List

Relief Cardiovascular Secures M Series A to Advance Smart Implant for Heart Failure Management

January 9, 2025

Relief Cardiovascular, a portfolio company of inQB8 Medical Technologies, has raised $12 million in a Series A financing round to fund the development…

November 12, 2024

Acepodia is a clinical-stage biotechnology company developing accessible cancer cell therapies using its Antibody-Cell Conjugation (ACC) technology. By linking tumor-targeting antibodies to immune…

November 12, 2024

BillionToOne is a precision diagnostics company on a mission to advance prenatal screening and liquid biopsy. Their proprietary molecular counting platform accurately counts…

November 12, 2024

Maplight is a biopharmaceutical company developing novel therapeutics for patients with central nervous system (CNS) disorders, including Autism Spectrum Disorder, Parkinson’s Disease, and…

November 12, 2024

Evommune is a clinical-stage biotechnology company developing novel therapies for immune-mediated chronic inflammatory diseases, aiming to address root causes rather than just symptoms,…

November 12, 2024

Octave® Bioscience is a precision-medicine company revolutionizing the care of neurodegenerative diseases like Multiple Sclerosis. Their innovative Precision Care Solution includes the Octave…

November 12, 2024

Antheia is transforming pharmaceutical supply chains by using synthetic biology to engineer complex molecules in yeast, enabling the development of plant-inspired medicines. This…

November 12, 2024

LTZ Therapeutics is a global biotech company focused on immunotherapy, developing innovative treatments for oncology and autoimmune diseases. Its pioneering myeloid engager platform…

November 12, 2024

EpiBiologics is a California-based biotechnology company specializing in antibody-based protein degradation solutions for membrane and extracellular drug targets, aiming to advance therapeutic development….

November 12, 2024

AN2 Therapeutics is a biopharmaceutical company focused on developing therapies for rare, chronic, and serious infectious diseases in areas with high unmet medical…